Epitope expands HIV test agreement with LabOne:
This article was originally published in Clinica
LabOne is to use Epitope's OraSure device for HIV saliva testing in the public health, correction, military and college health markets. LabOne, which markets laboratory testing services in the US and Canada, already uses OraSure in its insurance testing division. LabOne will undertake kit assembly, distribution, testing and reporting of results for Beaverton, Oregan-based Epitope.
You may also be interested in...
As sector awaits its aducanumab filing with bated breath, Biogen invests again in early stage neuroscience.
In case you missed it: catch up with snippets from interviews with industry leaders recently published by In Vivo.
While good clinical practice inspectors in the UK and the US collaborate on matters of common interest, they say that mutual recognition is simply not possible.